LLGL1

LLGL1 is an evolutionarily conserved basolateral polarity scaffold that enforces epithelial architecture and acts as a tumor suppressor within the Lgl-Dlg-Scrib polarity module, as established by its ability to functionally substitute for Drosophila Lgl in vivo to restore Dlg/Scrib localization and prevent neoplastic overgrowth (PMID:15467749). Its activity is governed by a phospho-regulatory cycle: the apical aPKCι-Par6α complex captures full-length LLGL1 into a tripartite assembly via an aPKCι docking site and a Par6 PDZ contact, generating a phospho-S663 intermediate, with Cdc42-GTP and the apical determinant Crumbs driving complex disassembly to complete the phosphorylation cycle [PMID:bio_10.1101_2024.09.26.615224]. Phosphorylation by aPKC inhibits the direct binding of LLGL1 to N-cadherin, which in the unphosphorylated state drives N-cadherin internalization and restricts apical junctional complexes to the basolateral-apical boundary; disrupting this interaction during cortical development causes periventricular heterotopia (PMID:28552558). LLGL1 functions through its WD-40 repeat domain, which mediates the protein-protein interactions required for its cellular function (PMID:16969496), and operates within a hScrib/hDlg/Hugl-1 complex that engages the t-SNARE syntaxin 4, linking polarity to vesicle transport (PMID:18793635). LLGL1 protein levels are set post-translationally by USP11, which deubiquitinates and stabilizes LLGL1 in a RanBPM-dependent manner (PMID:26919101). Loss of LLGL1 unleashes oncogenic signaling—EGFR mislocalization with downstream AKT and TAZ/Slug nuclear translocation (PMID:27542214), ERK2/Sp1-driven OSMR transcription conferring drug resistance (PMID:32615164), and aPKC-NF-κB activation cooperating with Trp53 loss to drive carcinoma (PMID:36945368)—while in context-specific roles it stabilizes Yap protein in cardiomyocytes (PMID:32843528) and sustains HoxA9-dependent stemness in AML (PMID:37587260).

1. 2003 Low

   Establishing whether mammalian Lgl-family genes retain the ancestral function of their yeast and fly counterparts was the first step in attributing any conserved cellular role to LLGL1.

   Evidence Yeast complementation rescuing salt tolerance in Sop1/Sop2-deficient cells with mouse Mgl-1

   PMID:14612921

   Open questions at the time

   • Single heterologous complementation assay only
   • No molecular mechanism for the complemented function
   • Does not address mammalian-specific roles
2. 2004 High

   It was unknown whether human LLGL1 operates in the same tumor-suppressive polarity pathway as Drosophila Lgl; cross-species genetic complementation placed it firmly within the Lgl-Dlg-Scrib module.

   Evidence Transgenic rescue of Drosophila lgl-null mutants with human HUGL-1, scoring lethality and Dlg/Scrib localization

   PMID:15467749

   Open questions at the time

   • Does not identify the direct molecular partners of LLGL1 in mammals
   • Pathway placement inferred from fly markers, not mammalian biochemistry
3. 2005 Low

   Whether re-expressing LLGL1 in carcinoma cells reverses malignant behavior was tested to validate its tumor-suppressor function at the cellular level.

   Evidence Inducible HUGL-1 expression in colorectal cancer lines with adhesion and migration assays

   PMID:15735678

   Open questions at the time

   • Single overexpression experiment without pathway placement
   • No mechanism linking adhesion/migration change to a molecular target
4. 2006 Medium

   The structural basis for LLGL1's protein interactions and its capacity to suppress EMT markers were addressed to connect domain architecture and phenotype.

   Evidence WD-40 residue mutagenesis with yeast complementation, and melanoma re-expression scoring E-cadherin/MMP levels

   PMID:16170365 PMID:16969496

   Open questions at the time

   • WD-40 partners not identified
   • EMT marker changes are correlative, no direct binding shown
   • Melanoma data is overexpression-based, single lab
5. 2008 Medium

   Defining the composition and dependencies of the mammalian Scrib polarity complex clarified how LLGL1 is positioned and linked it to membrane trafficking.

   Evidence hScrib shRNA knockdown with co-localization and syntaxin 4 co-immunoprecipitation

   PMID:18793635

   Open questions at the time

   • Direct vs indirect LLGL1-syntaxin 4 contact not resolved
   • Functional consequence of the t-SNARE link not tested
   • Single lab
6. 2012 Medium

   How LLGL1-controlled apical domain size feeds into developmental signaling was unknown; epistasis placed it upstream of Notch-dependent neurogenesis.

   Evidence Conditional Llgl1 knockout in zebrafish retina with Rbpj-depletion and Shroom3-inhibition epistasis

   PMID:22492354

   Open questions at the time

   • Molecular link between apical domain expansion and Notch activation unresolved
   • Tissue-specific to retinal neuroepithelium
7. 2016 Medium

   Two complementary mechanisms of LLGL1 regulation were defined: how its loss activates oncogenic EGFR signaling, and how its protein abundance is controlled post-translationally.

   Evidence Llgl1 knockout cells with EGFR P667A point mutant and mammosphere/transplant assays; USP11 deubiquitination assay with RanBPM knockdown epistasis

   PMID:26919101 PMID:27542214

   Open questions at the time

   • Mechanism by which LLGL1 controls EGFR localization not defined
   • How RanBPM enables USP11 access to LLGL1 unknown
   • Single lab for each finding
8. 2017 High

   The direct molecular substrate of LLGL1 polarity activity was identified, linking aPKC phosphorylation to N-cadherin trafficking and a defined developmental disease.

   Evidence Reciprocal Co-IP, live cortical imaging, conditional knockout, and N-cadherin interaction point mutants causing periventricular heterotopia

   PMID:28552558

   Open questions at the time

   • Internalization machinery downstream of LLGL1-N-cadherin not detailed
   • Whether this mechanism operates in non-neural epithelia not tested
9. 2020 Medium

   Context-specific signaling outputs of LLGL1 were established: Yap protein stabilization in cardiomyocytes and ERK2/Sp1-driven OSMR transcription conferring drug resistance.

   Evidence Zebrafish morpholino knockdown with cardiomyocyte Yap rescue; genome-wide RNAi screen with Sp1 ChIP at the OSMR promoter and OSMR knockdown rescue

   PMID:32615164 PMID:32843528

   Open questions at the time

   • Mechanism by which LLGL1 stabilizes Yap protein unknown
   • How LLGL1 loss triggers ERK2/Sp1 phosphorylation not defined
   • Both context-specific, single lab each
10. 2023 Medium

    LLGL1 was shown to have a stemness-maintaining role beyond classical polarity, and its loss to cooperate with Trp53 in carcinogenesis via aPKC-NF-κB.

    Evidence CRISPR screening in AML models with HoxA9 re-expression rescue; conditional Llgl1/Llgl2 double knockout crossed with Trp53 cKO in mouse epidermis

    PMID:36945368 PMID:37587260

    Open questions at the time

    • Mechanism linking LLGL1 to HoxA gene expression unknown
    • Redundancy with Llgl2 complicates single-gene attribution
    • Epidermal study is a preprint
11. 2024 High

    The atomic basis of LLGL1's phospho-regulatory cycle was resolved, and a new tissue-morphogenesis role in epicardial emergence and apical laminin deposition was defined.

    Evidence Cryo-EM of the aPKCι-Par6α-LLGL1 tripartite complex with docking/PDZ mutagenesis and in vitro kinase assays; zebrafish llgl1 mutant epicardial lineage imaging and laminin immunofluorescence

    PMID:38940292 PMID:bio_10.1101_2024.09.26.615224

    Open questions at the time

    • Structural work is a preprint
    • Precise role of Cdc42-GTP/Crumbs in disassembly defined biochemically but not in tissue
    • Link between LLGL1 and laminin deposition mechanism unresolved

• How a single basolateral scaffold integrates its conserved polarity/N-cadherin function with the diverse downstream outputs (Yap, HoxA9, EGFR, OSMR, NF-κB) remains the central unresolved question.
• No unifying mechanism connecting polarity scaffolding to transcriptional/signaling outputs
• Direct WD-40 domain interactome largely uncharacterized
• Whether outputs are direct or secondary to polarity loss unknown